Comparative inhibitory activity of the stilbenes resveratrol and oxyresveratrol on African swine fever virus replication

Antiviral Research

Volumn 91, Issue 1, 2011, Pages 57-63

  Galindo, I ^a   Hernaez B ^a   Berna J ^b   Fenoll, J ^c   Cenis, J L ^c   Escribano, J M ^a   Alonso, C ^a  

^a INIA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

^c INSTITUTO MURCIANO DE INVESTIGACIÓN Y DESARROLLO AGRARIO Y ALIMENTARIO IMIDA   (Spain)

Author keywords

African swine fever virus; Antiviral; Oxyresveratrol; Resveratrol

Indexed keywords

OXYRESVERATROL; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

AFRICAN SWINE FEVER VIRUS; ANIMAL CELL; ANIMAL CELL CULTURE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TITRATION;

AFRICAN SWINE FEVER VIRUS; ANIMALS; ANTIOXIDANTS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; DNA REPLICATION; PHYTOTHERAPY; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; PROTEIN SYNTHESIS INHIBITORS; STILBENES; VIRUS REPLICATION;

AFRICAN SWINE FEVER VIRUS; ASFARVIRIDAE; MORUS (ANGIOSPERM); SUS;

EID: 79957572786     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.04.013     Document Type: Article

References (41)

1. Andrabi S.A., Spina M.G., Lorenz P., Ebmeyer U., Wolf G., Horn T.F. Oxyresveratrol (trans-2,3′,4,5′-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia. Brain Res. 2004, 1017:98-107.
2. Ban J.Y., Jeon S.Y., Nguyen T.T., Bae K., Song K.S., Seong Y.H. Neuroprotective effect of oxyresveratrol from smilacis chinae rhizome on amyloid beta protein (25-35)-induced neurotoxicity in cultured rat cortical neurons. Biol. Pharm. Bull. 2006, 29:2419-2424.
3. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5:493-506.
4. Berardi V., Ricci F., Castelli M., Galati G., Risuleo G. Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical use. J. Exp. Clin. Cancer Res. 2009, 28:96.
5. Campagna M., Rivas C. Antiviral activity of resveratrol. Biochem. Soc. Trans. 2010, 38:50-53.
6. Cucciolla V., Borriello A., Oliva A., Galletti P., Zappia V., Della Ragione F. Resveratrol: from basic science to the clinic. Cell Cycle 2007, 6:2495-2510.
7. Chao J., Yu M.S., Ho Y.S., Wang M., Chang R.C. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic. Biol. Med. 2008, 45:1019-1026.
8. Cheltsov A.V., Aoyagi M., Aleshin A., Yu E.C., Gilliland T., Zhai D., Bobkov A.A., Reed J.C., Liddington R.C., Abagyan R. Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention. J. Med. Chem. 2010, 53:3899-3906.
9. Choi S.Y., Hwang J.S., Kim S., Kim S.Y. Synthesis, discovery and mechanism of 2,6-dimethoxy-N-(4-methoxyphenyl)benzamide as potent depigmenting agent in the skin. Biochem. Biophys. Res. Commun. 2006, 349:39-49.
10. Chuanasa T., Phromjai J., Lipipun V., Likhitwitayawuid K., Suzuki M., Pramyothin P., Hattori M., Shiraki K. Anti-herpes simplex virus (HSV-1) activity of oxyresveratrol derived from Thai medicinal plant: mechanism of action and therapeutic efficacy on cutaneous HSV-1 infection in mice. Antiviral Res. 2008, 80:62-70.
11. Delmas D., Lancon A., Colin D., Jannin B., Latruffe N. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr. Drug Targets 2006, 7:423-442.
12. Dixon L.K., Costa J.V., Escribano J.M., Rock D.L., Vinuela E., Wilkinson P.J. Virus taxonomy. Classification and nomenclature of viruses. Seventh Report of the International Committee on Taxonomy of Viruses 2000, 159-165. Academic Press, London. M.H.V. Van Regenmortel, C.M. Fauquet, D.H.L. Bishop, E. Carstens, M.K. Estes, S. Lemon, J. Maniloff, M.A. Mayo, D.J. McGeoch, C.R. Pringle, R. Wickner (Eds.).
13. Docherty J.J., Fu M.M., Stiffler B.S., Limperos R.J., Pokabla C.M., DeLucia A.L. Resveratrol inhibition of herpes simplex virus replication. Antiviral Res. 1999, 43:145-155.
14. Docherty J.J., Sweet T.J., Bailey E., Faith S.A., Booth T. Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Res. 2006, 72:171-177.
15. Enjuanes L., Carrascosa A.L., Moreno M.A., Viñ/uela E. Titration of African swine fever (ASF) virus. J. Gen. Virol. 1976, 32:471-477.
16. Evers D.L., Wang X., Huong S.M., Huang D.Y., Huang E.S. 3,4′,5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling. Antiviral Res. 2004, 63:85-95.
17. Fabregas J., Garcia D., Fernandez-Alonso M., Rocha A.I., Gómez-Puertas P., Escribano J.M., Otero A., Coll J.M. In vitro inhibition of the replication of haemorrhagic septicaemia virus (VHSV) and African swine fever virus (ASFV) by extracts from marine microalgae. Antiviral Res. 1999, 44:67-73.
18. Heredia A., Davis C., Redfield R. Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol. J. Acquir. Immune Defic. Syndr. 2000, 25:246-255.
19. Hernáez B., Alonso C. Dynamin- and clathrin-dependent endocytosis in African swine fever virus entry. J. Virol. 2010, 84:2100-2109.
20. Hernáez B., Escribano J.M., Alonso C. Visualization of the African swine fever virus infection in living cells by incorporation into the virus particle of green fluorescent protein-p54 membrane protein chimera. Virology 2006, 350:1-14.
21. Hernáez B., Tarragó T., Giralt E., Escribano J.M., Alonso C. Small peptide inhibitors disrupt a high-affinity interaction between cytoplasmic dynein and a viral cargo protein. J. Virol. 2010, 84:10792-10801.
22. Hurtado C., Bustos M.J., Sabina P., Nogal M.L., Granja A.G., González M.E., Gónzalez-Porqué P., Revilla Y., Carrascosa A.L. Antiviral activity of lauryl gallate against animal viruses. Antivir. Ther. 2008, 13:909-917.
23. Juan M.E., Wenzel U., Daniel H., Planas J.M. Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells. J. Agric. Food Chem. 2008, 56:4813-4818.
24. Kapadia G.J., Azuine M.A., Tokuda H., Takasaki M., Mukainaka T., Konoshima T., Nishino H. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol. Res. 2002, 45:499-505.
25. King D.P., Reid S.M., Hutchings G.H., Grierson S.S., Wilkinson P.J., Dixon L.K., Bastos A.D., Drew T.W. Development of a TaqMan PCR assay with internal amplification control for the detection of African swine fever virus. J. Virol. Methods 2003, 107:53-61.
26. Krishnan V., Zeichner S.L. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency. J. Virol. 2004, 78:9458-9473.
27. Langcake P., Pryce R.J. The production of resveratrol by Vitis vinifera and other members of the vitaceae as a response to infection or injury. Physiol. Plant Pathol. 1976, 9:77-86.
28. Li H., Cheng K.W., Cho C.H., He Z., Wang M. Oxyresveratrol as an antibrowning agent for cloudy apple juices and fresh-cut apples. J. Agric. Food Chem. 2007, 55:2604-2610.
29. Lorenz P., Roychowdhury S., Engelmann M., Wolf G., Horn T.F. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide 2003, 9:64-76.
30. Marques F.Z., Markus M.A., Morris B.J. Resveratrol: cellular actions of a potent natural chemical that confers a diversity of health benefits. Int. J. Biochem. Cell Biol. 2009, 41:2125-2128.
31. Nakamura M., Saito H., Ikeda M., Hokari R., Kato N., Hibi T., Miura S. An antioxidant resveratrol significantly enhanced replication of hepatitis C virus. World J. Gastroenterol. 2010, 16:184-192.
32. Palamara A.T., Nencioni L., Aquilano K., De Chiara G., Hernandez L., Cozzolino F., Ciriolo M.R., Garaci E. Inhibition of influenza A virus replication by resveratrol. J. Infect. Dis. 2005, 191:1719-1729.
33. Rodriguez F., Alcaraz C., Eiras A., Yanez R.J., Rodriguez J.M., Alonso C., Rodriguez J.F., Escribano J.M. Characterization and molecular basis of heterogeneity of the African swine fever virus envelope protein p54. J. Virol. 1994, 68:7244-7252.
34. Rodriguez F., Ley V., Gómez-Puertas P., García R., Rodriguez J.F., Escribano J.M. The structural protein p54 is essential for African swine fever virus viability. Virus Res. 1996, 40:161-167.
35. Saiko P., Pemberger M., Horvath Z., Savinc I., Grusch M., Handler N., Erker T., Jaeger W., Fritzer-Szekeres M., Szekeres T. Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: inhibition of ribonucleotide reductase activity. Oncol. Rep. 2008, 19:1621-1626.
36. Sasivimolphan P., Lipipun V., Likhitwitayawuid K., Takemoto M., Pramyothin P., Hattori M., Shiraki K. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro. Antiviral Res. 2009, 84:95-97.
37. Shin N.H., Ryu S.Y., Choi E.J., Kang S.H., Chang I.M., Min K.R., Kim Y. Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase. Biochem. Biophys. Res. Commun. 1998, 243:801-803.
38. Soleas G.J., Diamandis E.P., Goldberg D.M. Wine as a biological fluid: history, production, and role in disease prevention. J. Clin. Lab. Anal. 1997, 11:287-313.
39. Sritulakuk B., De-Eknamkul W., Likhitwitayawuid K. Tyrosinase inhibitors from Artocarpus lakoocha. Thai J. Pharm. Sci. 1998, 22:149-155.
40. Wang L.X., Heredia A., Song H., Zhang Z., Yu B., Davis C., Redfield R. Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity. J. Pharm. Sci. 2004, 93:2448-2457.
41. Zhang H.S., Zhou Y., Wu M.R., Zhou H.S., Xu F. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity. Life Sci. 2009, 85:484-489.